These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 8069589

  • 1. Enhanced antitumour effects using a combination of two antibodies conjugated to different drugs.
    Rowland AJ, McKenzie IF, Pietersz GA.
    J Drug Target; 1994; 2(2):113-21. PubMed ID: 8069589
    [Abstract] [Full Text] [Related]

  • 2. Selective enhancement of antitumor activity of N-acetyl melphalan upon conjugation to monoclonal antibodies.
    Smyth MJ, Pietersz GA, McKenzie IF.
    Cancer Res; 1987 Jan 01; 47(1):62-9. PubMed ID: 3791221
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Increased antitumor effect of immunoconjugates and tumor necrosis factor in vivo.
    Smyth MJ, Pietersz GA, McKenzie IF.
    Cancer Res; 1988 Jul 01; 48(13):3607-12. PubMed ID: 3259905
    [Abstract] [Full Text] [Related]

  • 6. In vitro and in vivo evaluation of human tumor necrosis factor-alpha (hTNFalpha) chemically conjugated to monoclonal antibody.
    Pietersz GA, Toohey B, McKenzie IF.
    J Drug Target; 1998 Jul 01; 5(2):109-20. PubMed ID: 9588867
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
    Xu F, Leadon SA, Yu Y, Boyer CM, O'Briant K, Ward K, McWatters A, Zhao X, Bae DS, DeSombre K, Zalutsky MR, Bast RC.
    Clin Cancer Res; 2000 Aug 01; 6(8):3334-41. PubMed ID: 10955821
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antitumor effect of 2'-deoxy-5-fluorouridine conjugates against a murine thymoma and colon carcinoma xenografts.
    Krauer KG, McKenzie IF, Pietersz GA.
    Cancer Res; 1992 Jan 01; 52(1):132-7. PubMed ID: 1530766
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Use of vasoactive agents to increase tumor perfusion and the antitumor efficacy of drug-monoclonal antibody conjugates.
    Smyth MJ, Pietersz GA, McKenzie IF.
    J Natl Cancer Inst; 1987 Dec 01; 79(6):1367-73. PubMed ID: 2891866
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antitumor activity of T-2 toxin-conjugated monoclonal antibody to murine thymoma.
    Ohtani K, Murakami H, Shibuya O, Kawamura O, Ohi K, Chiba J, Otokawa M, Ueno Y.
    Jpn J Exp Med; 1990 Apr 01; 60(2):57-65. PubMed ID: 2384978
    [Abstract] [Full Text] [Related]

  • 15. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M, Benzo A, Irrissuto C, Lopez G, Curatella B, Maggi CA, Manzini S, Crea A, Caroli S, Cubadda F, Binaschi M.
    Cancer Chemother Pharmacol; 2008 Sep 01; 62(4):621-9. PubMed ID: 18038274
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.
    Scott CF, Goldmacher VS, Lambert JM, Jackson JV, McIntyre GD.
    J Natl Cancer Inst; 1987 Nov 01; 79(5):1163-72. PubMed ID: 3500356
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of an anti-CD7-ricin A chain immunoconjugate in a novel murine model of human T-cell leukemia.
    Fishwild DM, Aberle S, Bernhard SL, Kung AH.
    Cancer Res; 1992 Jun 01; 52(11):3056-62. PubMed ID: 1375534
    [Abstract] [Full Text] [Related]

  • 20. Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin.
    Flavell DJ, Boehm DA, Noss A, Warnes SL, Flavell SU.
    Br J Cancer; 2001 Feb 01; 84(4):571-8. PubMed ID: 11207056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.